Publications

• Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry

  (DesJardin JT, Kolaitis NA, Kime N, Kronmal RA, Benza RL, Elwing JM, Lammi MR, McConnell JW, Presberg KW, Sager JS, Shlobin OA, De Marco T.) Journal of Heart and Lung Transplantation. 2020 SCOPUS ID: 2-s2.0-85085742978 01/01/2020

• Pleuroparenchymal fibroelastosis (PPFE) treated with lung transplantation and review of the literature.

  (Ali MS, Ramalingam VS, Haasler G, Presberg K.) BMJ Case Rep. 2019 Apr 20;12(4) PMID: 31005872 SCOPUS ID: 2-s2.0-85065096490 04/22/2019

• A rare case of pneumocystis jirovecii pneumonia: In a nonimmunocompromised host

  (Patel JJ, Graham MB, Presberg KW, Ledeboer NA, Lipchik RJ.) Infectious Diseases in Clinical Practice. November 2011;19(6) SCOPUS ID: 2-s2.0-80855132856 11/01/2011

• A pulmonary consult

  (Zouras W, Presberg K.) Neurocritical Care. 1 January 2009:319-340 SCOPUS ID: 2-s2.0-84926082752 01/01/2009

• Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.

  (Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Furst DE, EPOSS-Omeract Group.) Arthritis Rheum. 2008 Jun 15;59(6):867-75 PMID: 18512721 06/03/2008

• Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study.

  (Bajaj JS, Dua KS, Hanson K, Presberg K.) Dig Dis Sci. 2007 Sep;52(9):2190-4 PMID: 17429726 SCOPUS ID: 2-s2.0-34547830318 04/13/2007

• Fulminant multisystem non-langerhans cell histiocytic proliferation with hemophagocytosis: a variant form of Erdheim-Chester disease.

  (Rao RN, Chang CC, Uysal N, Presberg K, Shidham VB, Tomashefski JF Jr.) Arch Pathol Lab Med. 2005 Feb;129(2):e39-43 PMID: 15679446 SCOPUS ID: 2-s2.0-21244490514 02/01/2005

• Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

  (McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G, American College of Chest Physicians.) Chest. 2004 Jul;126(1 Suppl):78S-92S PMID: 15249497 SCOPUS ID: 2-s2.0-3142777629 07/14/2004

• Current Management of Pulmonary Hypertension

  (Dincer HE, Presberg KW.) Clinical Pulmonary Medicine. January 2004;11(1):40-53 SCOPUS ID: 2-s2.0-1642540106 01/01/2004

• Pathophysiology of pulmonary hypertension due to lung disease.

  (Presberg KW, Dincer HE.) Curr Opin Pulm Med. 2003 Mar;9(2):131-8 PMID: 12574693 SCOPUS ID: 2-s2.0-12244259694 02/08/2003

• The hepatopulmonary syndrome: a case report and review of the literature.

  (Almoosa K, Presberg K.) WMJ. 2000 Sep;99(6):29-31, 34 PMID: 11061024 SCOPUS ID: 2-s2.0-0033735295 11/04/2000

• Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites

  (Zhu D, Birks EK, Dawson CA, Patel M, Falck JR, Presberg K, Roman RJ, Jacobs ER.) American Journal of Physiology. October 2000;279(4 PART 2) SCOPUS ID: 2-s2.0-0033713364 10/01/2000